A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic
What is the efficacy of combination chemotherapy and ruxolitinib for the treatment
of B-cell acute lymphoblastic leukemia in children?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This is a nonrandomized study of ruxolitinib in combination with a standard multi-agent
chemotherapy regimen for the treatment of B-cell acute lymphoblastic leukemia. Part
1 of the
study will optimize the dose of study drug (ruxolitinib) in combination with the chemotherapy
regimen. Part 2 will evaluate the efficacy of combination chemotherapy and ruxolitinib
recommended dose determined in Part 1.
Lead Researcher (Principal Investigator)
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search